Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
During Pregnancy
100%
Multiple Myeloma
92%
Myeloma Cells
63%
Chronic Lymphocytic Leukemia
58%
Fluorescence in Situ Hybridization
55%
Chemotherapy
54%
Pregnant Women
46%
Non-Hodgkin Lymphoma
41%
Lymphoma
38%
Chronic Myeloid Leukemia
34%
Placenta
33%
Cancer in Pregnancy
31%
Leukemia Patients
29%
Non-pregnant Women
29%
Lymphoma Patients
29%
Malignancy
28%
First Trimester
28%
Fetus
28%
Simvastatin
27%
Breast Cancer Cells
26%
Tetraspanin
26%
Bone Marrow
26%
Human Mesenchymal Stem Cells (hMSCs)
25%
Doxorubicin
25%
Leukemia
23%
Mesenchymal Stem Cells
23%
Translation Initiation
22%
Apoptosis
21%
Enalapril
21%
Statins
20%
Breast Cancer
19%
Heat Shock Protein 27 (HSP27)
19%
Polycythemia Vera
19%
Eukaryotic Translation Initiation Factor 4E (eIF4E)
19%
Microvesicles
19%
Hematological Malignancies
18%
B-CLL
18%
Essential Thrombocythemia
18%
Risk Factors
18%
Fetal Outcome
16%
Acute Myeloblastic Leukemia
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Aneuploidy
16%
Hodgkin Lymphoma
16%
Apoptosis Induction
16%
Myeloma
15%
Termination of Pregnancy
15%
Pregnancy-associated Cancer
15%
Maternal Outcomes
14%
Malignant Cells
14%
Medicine and Dentistry
Chemotherapy
64%
Malignant Neoplasm
56%
Cancer
45%
Diseases
37%
Non-Hodgkin Lymphoma
34%
Multiple Myeloma
32%
B-Cell Chronic Lymphocytic Leukemia
28%
Hodgkin's Lymphoma
27%
Doxorubicin
24%
First Trimester Pregnancy
23%
Breast Cancer
21%
Maturity Onset Diabetes of the Young
21%
Fluorescence in Situ Hybridization
20%
Congenital Malformation
18%
Pregnant Woman
17%
Ischemic Heart Disease
15%
Patient with Non-Hodgkins Lymphoma
15%
Leukemia
15%
Placebo
14%
Hematologic Malignancy
13%
Pregnancy Termination
13%
Diabetes Mellitus
13%
Neoplasm
13%
Nephropathy
13%
Kidney Function
12%
Biopsy Technique
12%
Cyclophosphamide
11%
Melanoma
11%
Creatinine
11%
Chronic Myelogenous Leukemia
11%
Monoclonal Gammopathy of Undetermined Significance
11%
Enalapril
11%
Low Density Lipoprotein Cholesterol
11%
Microsatellite Instability
11%
Lipid
11%
Cardiovascular Disease
10%
Placenta
10%
Cervical Cancer
10%
Prospective Study
9%
Antiphospholipid Syndrome
9%
Second Cancer
9%
Acute Leukemia
9%
Venous Thromboembolism
9%
Glucose
9%
Magnetic Resonance Imaging
9%
Motherisk
9%
Pathogenesis
9%
Cholesterol
9%
Leukocyte
9%
Lymphocyte
9%